Skip to Content

Bazedoxifene / conjugated estrogens Pregnancy and Breastfeeding Warnings

Bazedoxifene / conjugated estrogens is also known as: Duavee

Medically reviewed on Sep 6, 2018

Bazedoxifene / conjugated estrogens Pregnancy Warnings

FDA pregnancy category: X

Bazedoxifene-conjugated estrogens should not be used in women who are or may become pregnant.

No studies were performed on animals to evaluate the effects on reproduction.

There are no controlled data in human pregnancy.

FDA pregnancy category X: Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits.

See references

Bazedoxifene / conjugated estrogens Breastfeeding Warnings

Bazedoxifene-conjugated estrogens should not be used in lactating women.

Excreted into human milk: Unknown (bazedoxifene); Yes (estrogen)
Excreted into animal milk: Data not available

The effects in the nursing infant are unknown. Estrogen administered to nursing women decreases the quantity and quality of the milk.

See references

References for pregnancy information

  1. "Product Information. Duavee (bazedoxifene-conjugated estrogens)." Pfizer U.S. Pharmaceuticals Group, New York, NY.

References for breastfeeding information

  1. "Product Information. Duavee (bazedoxifene-conjugated estrogens)." Pfizer U.S. Pharmaceuticals Group, New York, NY.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide